- Home
- BNTX vs BAM Comparison
BNTX vs BAM Comparison
Compare BNTX & BAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- BAM
- Stock Information
- Founded
- BNTX 2008
- BAM 2022
- Country
- BNTX Germany
- BAM Canada
- Employees
- BNTX N/A
- BAM N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- BAM
- Sector
- BNTX Health Care
- BAM
- Exchange
- BNTX Nasdaq
- BAM Nasdaq
- Market Cap
- BNTX 27.0B
- BAM 21.8B
- IPO Year
- BNTX 2019
- BAM N/A
- Fundamental
- Price
- BNTX $117.25
- BAM $56.84
- Analyst Decision
- BNTX Strong Buy
- BAM Buy
- Analyst Count
- BNTX 16
- BAM 13
- Target Price
- BNTX $145.28
- BAM $53.21
- AVG Volume (30 Days)
- BNTX 645.3K
- BAM 903.6K
- Earning Date
- BNTX 11-04-2024
- BAM 02-12-2025
- Dividend Yield
- BNTX N/A
- BAM 2.68%
- EPS Growth
- BNTX N/A
- BAM N/A
- EPS
- BNTX N/A
- BAM 1.09
- Revenue
- BNTX $3,390,698,192.00
- BAM N/A
- Revenue This Year
- BNTX N/A
- BAM N/A
- Revenue Next Year
- BNTX N/A
- BAM $17.38
- P/E Ratio
- BNTX N/A
- BAM $52.09
- Revenue Growth
- BNTX N/A
- BAM N/A
- 52 Week Low
- BNTX $76.53
- BAM $37.29
- 52 Week High
- BNTX $131.49
- BAM $59.58
- Technical
- Relative Strength Index (RSI)
- BNTX 52.32
- BAM 58.39
- Support Level
- BNTX $111.20
- BAM $50.31
- Resistance Level
- BNTX $129.27
- BAM $55.79
- Average True Range (ATR)
- BNTX 4.37
- BAM 1.51
- MACD
- BNTX -0.47
- BAM 0.25
- Stochastic Oscillator
- BNTX 35.60
- BAM 97.90
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About BAM Brookfield Asset Management Inc Limited Voting Shares
Brookfield Asset Management Ltd engages in providing alternative asset management services through an ownership interest in a alternative asset management business. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies, and private wealth investors.